BURRA, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 35.641
EU - Europa 3.728
AS - Asia 3.617
AF - Africa 20
SA - Sud America 19
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 9
Totale 43.047
Nazione #
US - Stati Uniti d'America 35.607
CN - Cina 2.207
FI - Finlandia 861
IT - Italia 788
SG - Singapore 680
SE - Svezia 626
VN - Vietnam 550
DE - Germania 535
GB - Regno Unito 343
UA - Ucraina 292
IN - India 96
IE - Irlanda 54
NL - Olanda 42
GR - Grecia 36
ES - Italia 31
CA - Canada 28
FR - Francia 28
RU - Federazione Russa 25
TR - Turchia 22
BR - Brasile 12
HK - Hong Kong 12
PL - Polonia 12
RO - Romania 12
BE - Belgio 10
JP - Giappone 10
TW - Taiwan 10
EG - Egitto 8
CZ - Repubblica Ceca 7
IQ - Iraq 7
NZ - Nuova Zelanda 7
AU - Australia 6
IR - Iran 6
EU - Europa 5
MX - Messico 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BG - Bulgaria 4
CH - Svizzera 4
HU - Ungheria 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
CL - Cile 2
CO - Colombia 2
DK - Danimarca 2
ET - Etiopia 2
GH - Ghana 2
ID - Indonesia 2
LU - Lussemburgo 2
MA - Marocco 2
MY - Malesia 2
PH - Filippine 2
RS - Serbia 2
SI - Slovenia 2
SL - Sierra Leone 2
AF - Afghanistan, Repubblica islamica di 1
AR - Argentina 1
BD - Bangladesh 1
BZ - Belize 1
EC - Ecuador 1
EE - Estonia 1
HR - Croazia 1
IL - Israele 1
KR - Corea 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
PE - Perù 1
SA - Arabia Saudita 1
SC - Seychelles 1
TH - Thailandia 1
Totale 43.047
Città #
Fairfield 6.273
Woodbridge 4.070
Houston 3.069
Ann Arbor 2.877
Chandler 2.553
Ashburn 2.552
Seattle 2.185
Wilmington 2.077
Cambridge 2.056
Jacksonville 1.314
Princeton 846
San Diego 736
Dong Ket 546
Beijing 535
Des Moines 519
Medford 495
Singapore 394
Helsinki 379
Nanjing 351
Roxbury 317
Guangzhou 309
Boardman 258
Padova 228
Shenyang 138
Shanghai 121
Nanchang 98
London 94
Hebei 80
New York 78
Falls Church 77
Jiaxing 68
Ogden 61
Milan 57
Munich 54
Jinan 52
Tianjin 50
Dublin 48
Changsha 46
Norwalk 45
Redwood City 39
Los Angeles 35
Pune 34
Kilburn 32
Hefei 31
Kunming 31
Dearborn 29
Rome 29
Washington 29
Zhengzhou 28
Kharkiv 27
Borås 26
Chicago 24
Indiana 22
Vicenza 22
Ningbo 21
Chiswick 19
Lappeenranta 19
Phoenix 18
Fuzhou 16
Hangzhou 16
Rockville 16
Yenibosna 16
Venice 15
Prescot 14
Las Vegas 13
Detroit 12
Hong Kong 12
Taizhou 12
Tappahannock 12
Haikou 10
Taipei 10
Wandsworth 10
Esslingen am Neckar 9
Hounslow 9
Trieste 9
Amsterdam 8
Cologno Monzese 8
Lanzhou 8
Mestre 8
Nürnberg 8
Baghdad 7
Brno 7
Grafing 7
North York 7
Paris 7
Brussels 6
Costa Mesa 6
Dolo 6
Piacenza 6
Renton 6
San Francisco 6
São Paulo 6
Teramo 6
Acton 5
Bologna 5
Düsseldorf 5
Florence 5
Leawood 5
Madrid 5
New Bedfont 5
Totale 36.990
Nome #
Cavoportal hemitransposition associated to portoportal anastomosis for liver transplant in portomesenteric thrombosis. 158
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 158
Alcohol abuse and de novo tumors in liver transplantation 149
Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy 148
Model for end-stage liver disease-sodium and survival benefit in liver transplantation. 145
Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. 144
Fulminant hepatic failure: the issue of patient selection for hazardous liver assistance 143
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation:the first report on the application of VAC therapy 142
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. 142
The Psychomotor Vigilance Task: Role in the Diagnosis of Hepatic Encephalopathy and Relationship with Driving Ability 141
Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma 140
Prognostic Evaluation of the Donor Risk Index Among a Prospective Cohort of Italian Patients Undergoing Liver Transplantation 140
Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy 140
Health-related Quality of Life in Liver Transplantation: Another Step Forward 139
Torque Teno Virus: any pathological role in liver transplanted patients? 138
Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study 136
Hepatitis C virus eradication with direct acting antiviral improves insulin resistance 134
Understanding of and attitudes to xenotransplantation: a survey among Italian university students 131
Isoniazid-related fulminant hepatic failure in a child: assessment of the native liver's early regeneration after auxiliary partial orthotopic liver transplantation. 131
Liver Transplantation for Alcoholic Liver Disease in Europe: A Study from the ELTR (European Liver Transplant Registry) 130
Understanding of and attitudes to organ donation and transplantation: a survey among Italian university students 128
Cost-effectiveness of Pre-Transplant Sofosbuvir for Preventing Recurrent HCV Infection after Liver Transplantation. 128
The survival benefit of liver transplantation in hepatocellular carcinoma patients 127
Allocation of liver grafts worldwide – Is there a best system? 127
Inflammatory bowel disease therapies adversely affect fertility in men- A systematic review and meta-analysis 126
Nonadherent Behaviors After Solid Organ Transplantation 125
Acellular liver matrix improves the survival and functions of isolated rat hepatocytes cultured in vitro 125
New Perspectives in Liver Transplantation: From Regeneration to Bioengineering 125
18F-fluorodeoxyglucose positron emission tomography study of brain metabolism in cirrhosis: effect of liver transplantation 123
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 123
Combined liver-kidney transplantation in a 15-year-old boy with alpha1-antitrypsin deficiency 122
Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: impact on survival or HCV recurrence timing 122
The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? 122
The two faces of hepatocellular carcinoma prognostic evaluation: 'observational' or 'pragmatic' approach? 122
Evaluation of compliance in patients with chronic liver disease 121
Growth hormone/insulin-like growth factor 1 axis recovery after liver transplantation: A preliminary prospective study 121
A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY 120
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the milan criteria 120
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis 120
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. 120
Antiviral treatment for HCV recurrence after liver transplantation: when, how much and for how long? 119
Is osteopenia a peculiar association with primary biliary cirrhosis (PBC)? 118
Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation. 118
Zinc, iron, and peroxidation in liver tissue. Cumulative effects of alcohol consumption and virus-mediated damage--a preliminary report. 117
Study of the microcirculation in hDAF transgenic rat livers xenoperfused with human blood. 117
Donor-Model for End-Stage Liver Disease and Donor-Recipient Matching in Liver Transplantation 117
Sex-dependent differences in inflammatory responses during liver regeneration in a murine model of acute liver injury. 117
Long-Term Follow-Up and Outcome of Liver Transplantation From Anti-Hepatitis C Virus-Positive Donors: A European Multicentric Case-Control Study 116
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC 116
Ductular reaction and hepatocyte ballooning identify patients with fibrosing cholestatic hepatitits after liver transplantation 116
Alphafetoprotein and Transplant Survival Benefit For Patients With Hepatocellular Carcinoma: A Multicentre Cohort Study 115
A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. 115
Changing attitude to organ donation and transplantation in university students during the years of medical school in Italy. 114
Microwave Thermal Ablation for Hepatocarcinoma: Six Liver Transplantation Cases 114
Antibiotic prophylaxis for preventing postorthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid? 114
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 114
Meld-na and Survival Benefit In Liver Transplantation 113
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy 113
Experimental hepatology applied to stem cells 113
New Perspectives on Treatment of Hepatitis B Before and After Liver Transplantation 112
Alcohol metabolism in the upper digestive tract: its implications with respect to carcinogenesis. 112
De novo tumors are a major cause of late mortality after orthotopic liver transplantation. 110
Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure 110
Liver Transplantation In Cirrhotic Patients With Meld Score < 18: A New Prognostic Model To Predict Drop-out From the Waiting List 109
Common issues in the management of patients in the waiting list and after liver transplantation 109
Different neurological outcome of liver transplantation for Wilson's disease in two homozygotic twins 109
Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies. 108
"DAA in patients with Hepatocellular carcinoma before Liver Transplantation: are we sure is still an open issue?" 108
The transjugular route: the key hole to the liver world 107
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy 107
A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a "blended Principle Model" 107
Sorafenib use in the transplant setting. 106
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. 106
Markers of acute rejection and graft acceptance in liver transplantation. 106
Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics 106
Influence of steroids on HCV recurrence after liver transplantation: A prospective study 105
Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure ? 105
Survival Benefit of Transplantation for Recurrence of Hepatocellular Carcinoma After Liver Resection 105
Alcohol-Related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study 105
AISF position paper on HCV in immunocompromised patients 105
A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY 105
Severe small bowel pneumatosis in adult heart transplant recipient. 104
Progression of hepatocellular carcinoma before liver transplantation: dropout or liver transplantation? 104
Regional cerebral blood flow changes in patients with cirrhosis assessed with 99m Tc-H-PAO single-photon emission computed tomography: effect of liver transplantation" 104
CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential 104
Hepatitis C virus infection in end stage renal disease and kidney transplantation 104
Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor 104
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma 104
Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): The role of angiogenesis and invasiveness 103
Erratum to "A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list" [J Hepatol 2013;60:290-297]. 103
A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis 103
Antiviral therapy for hepatitis C virus recurrence following liver transplantation: Long-term results from a single center experience 102
A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis 102
De Novo Auto-immune Hepatitis and Hcv Recurrence After Liver Transplantation: A Challenging Diagnosis and Poor Prognosis 101
Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors 101
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 101
THE SURVIVAL BENEFIT OF LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA 100
Successful pregnancy in a liver transplant recipient treated with lamivudine for de novo hepatitis B in the graft. 100
Normal cortical regional cerebral blood flow justifies the normal neuropsychological performance in patients with cholestatic liver disease 100
A Prioritization Model for Liver Transplantation Based on a Dual Waiting List: A Prospective Controlled Study 100
Totale 11.798
Categoria #
all - tutte 168.182
article - articoli 156.546
book - libri 227
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.204
Totale 327.159


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.041 0 357 224 866 1.021 732 929 1.051 1.007 880 618 356
2020/20216.453 332 463 435 556 293 353 233 576 885 566 720 1.041
2021/20228.645 220 995 1.087 533 300 641 817 816 336 229 1.039 1.632
2022/20235.716 1.242 473 124 595 985 787 62 376 675 43 268 86
2023/20243.577 207 476 385 259 237 290 294 129 167 396 357 380
2024/202541 30 11 0 0 0 0 0 0 0 0 0 0
Totale 43.632